Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
McKesson
Colorcon
Teva
Healthtrust
Moodys
Covington
Medtronic
Boehringer Ingelheim
Novartis

Generated: October 17, 2017

DrugPatentWatch Database Preview

VALTREX Drug Profile

« Back to Dashboard

What is the patent landscape for Valtrex, and when can generic versions of Valtrex launch?

Valtrex is a drug marketed by Glaxosmithkline and is included in one NDA. There are two patents protecting this drug.

This drug has one hundred and six patent family members in forty-five countries.

The generic ingredient in VALTREX is valacyclovir hydrochloride. There are twenty-two drug master file entries for this compound. Forty-nine suppliers are listed for this compound. Additional details are available on the valacyclovir hydrochloride profile page.

Summary for Tradename: VALTREX

US Patents:2
Applicants:1
NDAs:1
Suppliers / Packagers: see list7
Bulk Api Vendors: see list46
Clinical Trials: see list48
Patent Applications: see list4,305
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:VALTREX at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline
VALTREX
valacyclovir hydrochloride
TABLET;ORAL020487-002Jun 23, 1995ABRXYesYes► Subscribe► Subscribe ► Subscribe
Glaxosmithkline
VALTREX
valacyclovir hydrochloride
TABLET;ORAL020487-001Jun 23, 1995ABRXYesNo► Subscribe► Subscribe ► Subscribe
Glaxosmithkline
VALTREX
valacyclovir hydrochloride
TABLET;ORAL020487-002Jun 23, 1995ABRXYesYes► Subscribe► Subscribe ► Subscribe
Glaxosmithkline
VALTREX
valacyclovir hydrochloride
TABLET;ORAL020487-001Jun 23, 1995ABRXYesNo► Subscribe► Subscribe ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: VALTREX

International Patent Family for Tradename: VALTREX

Country Document Number Estimated Expiration
Japan3176633► Subscribe
Spain2248806► Subscribe
Australia4453996► Subscribe
Estonia03336► Subscribe
China1131026► Subscribe
Estonia9700175► Subscribe
United Kingdom9501127► Subscribe
Norway973327► Subscribe
Mexico9705459► Subscribe
Argentina002270► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Chubb
Cantor Fitzgerald
Fish and Richardson
Fuji
Moodys
Daiichi Sankyo
Federal Trade Commission
Mallinckrodt
Chinese Patent Office
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot